Log In
Print this Print this

EP-200 (formerly EP200)

  Manage Alerts
Collapse Summary General Information
Company Esperance Pharmaceuticals Inc.
DescriptionPeptide conjugate
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors (breast, prostate, endometrial, ovarian)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today